CAPR Icon

$CAPR

$CAPR

Capricor Therapeutics

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatm...

Stocks

Total Asset Value

$305

+40.91%from 30d ago

Holders

32

+77.78%from 30d ago

Monthly Transfer Volume

$6,201.62

86.71%from 30d ago

Tokenized Stock Metrics

Show % of Total

Tokenized Public Stocks

Loading...